B R Brehm
Overview
Explore the profile of B R Brehm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franz M, Grun K, Richter P, Brehm B, Fritzenwanger M, Hekmat K, et al.
Histochem Cell Biol
. 2010 Oct;
134(5):503-17.
PMID: 20931338
Chronic cardiac rejection is represented by cardiac allograft vasculopathy (CAV) and cardiac interstitial fibrosis (CIF) known to cause severe complications. These processes are accompanied by remarkable changes in the cardiac...
2.
Zurn C, Brehm B, Rub N, Langer H, Klingel K, Krober S, et al.
Internist (Berl)
. 2006 Oct;
47(11):1165-71.
PMID: 17013592
A 31-year-old woman presented with neurological deficits after an operation for sinusitis. The cranial MRI revealed multiple ischaemic lesions. Laboratory results showed a hypereosinophilia as well as elevated creatine kinase...
3.
Wolf S, MAYER O, Jurgens S, Vonthein R, Schultze G, Risler T, et al.
Clin Nephrol
. 2003 Apr;
59(4):273-9.
PMID: 12708567
Background: Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in patients with chronic renal failure undergoing dialysis therapy. Aim of the study was to evaluate whether there...
4.
Brehm B, Wolf S, Bertsch D, Klaussner M, Wesselborg S, Schuler S, et al.
Cardiovasc Res
. 2001 Feb;
49(2):430-9.
PMID: 11164853
Objective: Secondary failure due to late restenosis continues to occur in 30-50% of individuals after PTCA. beta-Blockers play an important role in the treatment of CAD. The aim of this...
5.
Brehm B, Bock C, Wesselborg S, Pfeiffer S, Schuler S, Schulze-Osthoff K
Biochem Pharmacol
. 2001 Jan;
61(1):119-27.
PMID: 11137716
Despite significant improvements in the treatment of atherosclerotic disease involving procedures such as angioplasty, bypass grafting, endartherectomy, or stent implantation, secondary failure due to late restenosis still occurs in 30-50%...
6.
Brehm B, Bertsch D, von Fallois J, Wolf S
J Cardiovasc Pharmacol
. 2000 Nov;
36(5 Suppl 1):S401-3.
PMID: 11078433
Endothelin-1 (ET-1) plays an important role in atherogenesis. The aim of the study reported here was to investigate the effects of the third generation beta-blockers nebivolol and carvedilol on ET-1...
7.
Wolf S, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T, et al.
J Cardiovasc Pharmacol
. 2000 Nov;
36(5 Suppl 1):S348-50.
PMID: 11078417
Increased endothelin-1 (ET-1) levels were found in patients with chronic renal failure. These correlate with the severity of renal failure. Patients with elevated ET-1 concentrations show an increased cardiovascular mortality....
8.
Brehm B, Heinle H, Risler T, Wolf S
J Cardiovasc Pharmacol
. 2000 Nov;
36(5 Suppl 1):S157-9.
PMID: 11078365
In atherosclerosis and heart failure chronically elevated endothelin-1 (ET-1) plasma concentrations have been found which correlate with an increased mortality. The aim of this study was to determine the effects...
9.
Wolf S, Brehm B, Gaschler F, Brehm S, Klaussner M, Smykowski J, et al.
Nephrol Dial Transplant
. 1999 Aug;
14 Suppl 4:29-30.
PMID: 10463205
The present study suggests that ET-1 is involved in the pathogenesis of uraemic cardiac hypertrophy and in the progression of renal failure in rats with subtotal nephrectomy examined after an...
10.
Brehm B, Meergans M, Axel D, Pfohl M, Heinle H, Karsch K
Cardiovasc Res
. 1998 Aug;
38(2):522-30.
PMID: 9709415
Objective: Vasodilation by beta-adrenergic receptors of smooth muscle cells appears to be impaired early after the onset of hypercholesteremia. The aim of this study was to analyze the modulation of...